Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,474,521
+$965,325 QoQ
Shares Held
39,223
-4.2% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#194
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OSSIAM holds $190,268,884 across 10 Drug Manufacturers - General names. BIIB ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,300 | $108,308,538 | |
| 2 | AZN |
Astrazeneca PLC
|
80,256 | $15,218,142 | |
| 3 | AMGN |
Amgen Inc
|
36,294 | $13,142,783 | |
| 4 | ABBV |
AbbVie Inc.
|
50,502 | $12,708,323 | |
| 5 | MRK |
Merck & Co., Inc.
|
91,787 | $11,794,629 | |
| 6 | BIIB |
Biogen Inc.
This page
|
39,223 | $8,474,521 | |
| 7 | PFE |
Pfizer Inc
|
275,753 | $6,640,132 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
49,573 | $6,263,052 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,474,521 | 39,223 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,509,196 | 40,960 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $10,957,665 | 62,263 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $9,189,668 | 65,603 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,340,662 | 50,487 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $7,140,448 | 52,181 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $7,701,509 | 50,363 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,248,106 | 47,710 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,493,260 | 40,951 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,458,457 | 25,314 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,405,997 | 28,620 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,575,395 | 33,366 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $15,281,063 | 53,646 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,552,906 | 37,956 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,475,606 | 37,829 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $16,196,220 | 60,660 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,146,380 | 64,462 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,439,931 | 59,069 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $16,821,510 | 70,113 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,814,156 | 48,815 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $14,136,819 | 40,826 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,997,610 | 60,760 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,142,109 | 45,504 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $16,174,866 | 57,018 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $14,748,961 | 55,126 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,127,261 | 3,563 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||